Voyager Therapeutics, Inc. — Form D

Voyager Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-17. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Grace A ColonDirectorLexington, MA
James A GeraghtyDirectorLexington, MA
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
Steven A HymanDirectorLexington, MA
Catherine A MackeyDirectorLexington, MA
Jude A OnyiaDirectorLexington, MA
Glenn A PierceDirectorLexington, MA
Alfred SandrockDirectorLexington, MA
George A ScangosDirectorLexington, MA
Nancy A VitaleDirectorLexington, MA
Todd CarterExecutive OfficerLexington, MA
Jacquelyn Fahey SandellExecutive OfficerLexington, MA
Peter PfreundschuhExecutive OfficerLexington, MA
Alfred SandrockExecutive OfficerLexington, MA
Robin SwartzExecutive OfficerLexington, MA
Steven PaulDirectorBoston, MA
Steven PaulExecutive OfficerBoston, MA
Mark LevinDirectorNew York, NY
Robert W HessleinExecutive OfficerCambridge, MA
Todd W CarterExecutive OfficerCambridge, MA
Robin W SwartzExecutive OfficerCambridge, MA
Michael W HigginsDirectorCambridge, MA
James GeraghtyDirectorCambridge, MA
Mitchell S BloomExecutive OfficerNew York, NY

Other filings by this issuer (2)

FiledFormOfferingSold
2023-03-03D$39.0M$39.0M
2015-04-23D$60.0M

More